Back to Screener

Pro-Dex, Inc. - Common Stock (PDEX)

NASDAQ Micro Cap

Healthcare › Surgical & Medical Instruments & Apparatus

$50.99
Market Cap: $163M
Data as of Dec 31, 2025 (TTM)

Price History

Feb 9, 2026 — Apr 2, 2026

Investment Snapshot

  • Trading 53% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 6/9 — moderate financial health
  • Strong ROE of 29.3% with 17.1% net margin
  • Revenue growing at 24% annually

Pro-Dex, Inc. - Common Stock (PDEX) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $163 million . Key value metrics: P/E ratio 13.4, P/B ratio 3.93, Piotroski F-Score 6 out of 9 (moderate financial health) .

Value Score

Key Metrics

P/E Ratio
13.42
3.93
EPS
$3.80
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

Pro-Dex, Inc. - Common Stock — Fundamental Analysis Summary

Pro-Dex, Inc. - Common Stock (PDEX) is currently trading 53% above its Graham Number of $33.32, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 13.4x.

On financial health, PDEX shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 29.3% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.37.

StockPik's composite Value Score for PDEX is 96/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

PDEX reports a moderate gross margin of 30.8% (sector average: 33.5%) and a solid operating margin of 17.8%.

PDEX shows revenue growing at 24% year-over-year, with earnings growing at 322%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
CYRX $8.21 4.7 100
CRMD $6.70 3.6 100
CGEN $2.06 5.5 100
ABEO $4.82 4.5 100
BDMD $2.01 5.8 100
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
PD
Next
PDFS